Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2018) Vol. 14, Iss. 2, pp. 242-242
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
Bruna De Felice, Concetta Montanino, Mariano Oliva, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4408-4416
Open Access | Times Cited: 28
MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer’s disease: a review
Amir Modarresi Chahardehi, Reza Arefnezhad, Alireza Pourbafrani, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
MicroRNA-669f-5p targeting deoxycytidinephosphate deaminase contributes to sevoflurane-induced cognitive impairments in aged mice via the TLR2/4–MyD88–NF-κB pathway
Yuanping Zhong, Chao Zhang, Li Yan Yuan, et al.
Brain Research Bulletin (2025), pp. 111381-111381
Open Access
Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: Present and future applications
Marcella Reale, Isabella Gonzales-Portillo, Cesar V. Borlongan
Brain Research (2019) Vol. 1727, pp. 146535-146535
Closed Access | Times Cited: 28
Molecular Changes in Circulating microRNAs’ Expression and Oxidative Stress in Adults with Mild Cognitive Impairment: A Biochemical and Molecular Study
Hadeel A. Al‐Rawaf, Ahmad H. Alghadir, Sami A. Gabr
Clinical Interventions in Aging (2021) Vol. Volume 16, pp. 57-70
Open Access | Times Cited: 22
MicroRNA and mRNA profiling of cerebral cortex in a transgenic mouse model of Alzheimer’s disease by RNA sequencing
Zhuorong Li, Rui Liu, Li Zeng, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 10, pp. 2099-2099
Open Access | Times Cited: 21
New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
Micaela Riscado, Bruno Baptista, Fani Sousa
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1397-1397
Open Access | Times Cited: 21
Direct, precise, enzyme-free detection of miR-103–3p in real samples by microgels with highly specific molecular beacons
Sabrina Napoletano, Edmondo Battista, Nicoletta Martone, et al.
Talanta (2023) Vol. 259, pp. 124468-124468
Open Access | Times Cited: 9
Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis
Renqing Zhao
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Biomarkers for Alzheimer's disease
Ernest K. J. Pauwels, Duccio Volterrani, Giuliano Mariani
Drug News & Perspectives (2009) Vol. 22, Iss. 3, pp. 151-151
Closed Access | Times Cited: 38
Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets
J. Weldon Furr, Diego Morales‐Scheihing, Bharti Manwani, et al.
NeuroMolecular Medicine (2019) Vol. 21, Iss. 4, pp. 369-390
Open Access | Times Cited: 25
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2020) Vol. 16, Iss. 3, pp. 440-440
Open Access | Times Cited: 22
A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease
Xuemei Zhao, John Kang, Vladimir Svetnik, et al.
The Journal of Applied Laboratory Medicine (2019) Vol. 5, Iss. 1, pp. 15-28
Closed Access | Times Cited: 20
Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis
Samar Zailaie, Jumana J. Siddiqui, Rawan Mansour Al Saadi, et al.
Immunological Investigations (2021) Vol. 51, Iss. 4, pp. 947-962
Closed Access | Times Cited: 18
Extracellular vesicle-packed microRNAs profiling in Alzheimer’s disease: The molecular intermediary between pathology and diagnosis
S. H. Arif, Talal Jamil Qazi, Zhenzhen Quan, et al.
Ageing Research Reviews (2024), pp. 102614-102614
Closed Access | Times Cited: 2
Estimating sparse functional brain networks with spatial constraints for MCI identification
Yanfang Xue, Limei Zhang, Lishan Qiao, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0235039-e0235039
Open Access | Times Cited: 16
Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments
Fatemehsadat Seyedaghamiri, Mojgan Rajabi, Gisou Mohaddes
Neurochemical Research (2022) Vol. 48, Iss. 1, pp. 26-38
Closed Access | Times Cited: 10
Cofilin 2 in Serum as a Novel Biomarker for Alzheimer’s Disease in Han Chinese
Yingni Sun, Lisheng Liang, Meili Dong, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 15
Risk Factors Associated with Mild Cognitive Impairment аmong Apparently Healthy People and the Role of MicroRNAs
Iman I. Salama, Somaia I Salama, Dalia M. Elmosalami, et al.
Open Access Macedonian Journal of Medical Sciences (2019) Vol. 7, Iss. 19, pp. 3253-3261
Open Access | Times Cited: 15
Multivariate Platelet Analysis Differentiates Between Patients with Alzheimer’s Disease and Healthy Controls at First Clinical Diagnosis
Isabella Wiest, Tim Wiemers, Max-Joseph Kraus, et al.
Journal of Alzheimer s Disease (2019) Vol. 71, Iss. 3, pp. 993-1004
Closed Access | Times Cited: 13
MicroRNAs in laser-induced choroidal neovascularization in mice and rats: their expression and potential therapeutic targets
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2020) Vol. 16, Iss. 4, pp. 621-621
Open Access | Times Cited: 11
A Concise Overview of Biosensing Technologies for the Detection of Alzheimer's Disease Biomarkers
Marjan Talebi, Hadi Esmaeeli, Mohsen Talebi, et al.
Current Pharmaceutical Biotechnology (2021) Vol. 23, Iss. 5, pp. 634-644
Closed Access | Times Cited: 10
Upregulated Blood miR-150-5p in Alzheimer’s Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy
Sook Yoong Chia, Ashwati Vipin, Kok Pin Ng, et al.
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 4, pp. 1567-1584
Closed Access | Times Cited: 7
Tissue Specific Reference Genes for MicroRNA Expression Analysis in a Mouse Model of Peripheral Nerve Injury
Theodora Kalpachidou, Kai K. Kummer, Miodrag Mitrić, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 10
Learning Brain Functional Networks With Latent Temporal Dependency for MCI Identification
Yanfang Xue, Yining Zhang, Limei Zhang, et al.
IEEE Transactions on Biomedical Engineering (2021) Vol. 69, Iss. 2, pp. 590-601
Closed Access | Times Cited: 9

Scroll to top